Company Filing History:
Years Active: 2025
Title: Jung-In Jang: Innovator in GLP-1 Receptor Agonist Development
Introduction
Jung-In Jang is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GLP-1 receptors. His work is crucial for advancing treatments for diseases associated with GLP-1 activity.
Latest Patents
Jang holds a patent for a GLP-1 receptor agonist, which is represented by a specific compound formula. This invention may serve as a valuable tool in the prevention or treatment of various diseases linked to GLP-1 activity. The patent highlights the potential of his compound and its pharmaceutically acceptable salts.
Career Highlights
Jang is currently employed at Hyundai Pharm Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise and dedication to research have positioned him as a key player in the development of new therapeutic agents.
Collaborations
Jang collaborates with esteemed colleagues, including Han Kyu Lee and Jeong-Un Hwang. Their combined efforts contribute to the advancement of research and development in their field.
Conclusion
Jung-In Jang's work in GLP-1 receptor agonists exemplifies the impact of innovative research in medicine. His contributions are paving the way for new treatment options and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.